EyePoint eye drug misses main goal in late-stage trial
17/08/2026 12:02
EyePoint eye drug misses main goal in late-stage trial Aug 17 (Reuters) - EyePoint EYPT.O said on Monday its experimental eye drug failed to meet its main goal in a late-stage trial.
(Reporting by Kamal Choudhury in Bengaluru)
Recent news on EyePoint
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
US STOCKS ON THE MOVE-CoreWeave, Moderna, Datadog
U.S. STOCKS ON THE MOVE-Amazon, CoreWeave, Moderna
U.S. STOCKS ON THE MOVE-Centrus Energy, Disc Medicine, Crypto
EyePoint to halve workforce after experimental drug fails second late-stage trial (updated)